Polyrizon (PLRZ) announced the preliminary safety study for a formulation of its PL-14 Allergy Blocker. Conducted on fully differentiated human ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful ...

Medically reviewed by Steffini Stalos, DO A fungal sinus infection, also called fungal sinusitis, is when fungus causes an infection of the sinuses. The sinuses are air-filled cavities in the head ...

Similarly, limiting alcohol consumption helps prevent nasal tissue inflammation that can contribute to both allergic symptoms and sinus obstruction. When to seek immediate medical attention for ...

The laser, combined with a special solution of salt water, gets rid of the unwanted tissue and relieves the symptoms of a condition that can cause a blocked nose, face pain, headaches and fever.

The study, leveraging the MucilAir™ model on human nasal tissue, showcased the product’s strong local tolerability, a key step in its development pathway. With a market capitalization of just $1.46 ...

The team recently conducted a clinical trial testing two smell aid prototypes designed to increase airflow to the nasal cavity tissue responsible for the sense of smell. One prototype is a nasal ...

Previous studies have shown that vitamin D is deficient in the nasal tissue of smokers. While applying vitamin D directly to the tissue might seem straightforward, doing so runs counter to the ...

Conducted on fully differentiated human nasal tissue using the MucilAir™ model, the study demonstrated strong local tolerability, a critical benchmark in the product development roadmap.